Skip to main content

ChronoScale Holdings Corp

corporate_fare Company Profile

ChronoScale Holdings Corp

CHRN·NASDAQ·Technology·CIK 0001549084

ChronoScale Holdings Corp operates its business through two wholly-owned subsidiaries: ChronoScale Corporation (formerly Applied Digital Cloud Corporation) and Ekso Bionics, Inc. Through ChronoScale Corporation, the company provides cloud services to customers at third-party colocation centers in Colorado, Minnesota, and Utah. These services support artificial intelligence and machine learning developers in developing advanced products. Customers pay a fixed rate for energized space supported by ChronoScale Corporation-provided equipment. Through Ekso Bionics, Inc., the company designs, develops, and markets exoskeleton and complementary products that augment human strength, endurance, and mobility. On May 29, 2026, the Board of Directors committed to a plan to divest the Ekso Bionics, Inc. business and focus operations solely on the cloud business, a plan publicly announced on June 4, 2026. The divestiture of Ekso Bionics, Inc. is expected to be completed during fiscal year 2027, and this business has been designated as "held for sale." On May 5, 2026, the company completed a business combination transaction, where Ekso Bionics Holdings, Inc. changed its name to "ChronoScale Corporation" and ChronoScale Corporation (formerly Applied Digital Cloud Corporation) became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc.

ChronoScale Holdings Corp (NASDAQ:CHRN) is a publicly traded company in the Technology sector. Wiseek has independently scored 11 items for CHRN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 10/10, with 8 rated 8 or above. Recent SEC coverage for CHRN spans 8-K, PRER14A, 10-K, 8-K/A.

Recent high-impact activity:

  • ChronoScale Completes Ekso Bionics Sale, Terminates COO, and Withdraws Series B Preferred Stock
  • $1 Billion AI Revenue Secured, ChronoScale Divests Bionics Unit
  • CTO Rajasekar Jegannathan Resigns Effective October 2, 2026
  • ChronoScale Extends Microsoft AI Compute Partnership to Three Years
  • ChronoScale and Microsoft Plan 50 MW AI Compute Deployment with NVIDIA GB300 Systems

Financial Snapshot

Fiscal year ended May 31, 2026
Revenue
$71.6M
Net Income
-$50.32M
Diluted EPS
-$0.36
Op. Cash Flow
$39.07M
Free Cash Flow
$12.19M
Gross Profit
-$17.09M
Operating Income
-$37.5M
Cash & Equivalents
$9.66M
Total Debt
$3.84M
Debt / Equity
0.02×
Net Margin
-70.3%
Shares Outstanding
145.21M sh
Source: 10-K · filed 2026-08-19 · accession 0001628280-26-058018

Short Interest & Short Volume

5.18 days to cover

FINRA reported short interest of 701,226 shares in CHRN as of the September 15, 2026 settlement, a 9.8% increase from the prior period — about 5.2 days to cover at its recent average daily volume. On October 2, 2026, 55.8% of CHRN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)701,226 shares as of September 15, 2026
Change vs prior period▲ 9.8%
Days to cover5.18 at avg daily volume of 135,258
Daily short volume (FINRA facilities)55.8% of 48,339 shares on October 2, 2026
5-day average short volume67.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for CHRN, detected from its recent SEC filings.

1 shelf registration

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$19.15 -0.06% today
52-week range · as of 2026-10-02 $3.5 – $30
Market cap
$2.8B
Volume
155.8K (1.1× avg)
3-mo avg 137.9K
Live data · 2026-10-04 05:20 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CHRN - Latest Insights

CHRN
Oct 02, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.21
Real-time Price: $19.15 info
Change: -$0.0552 (-0.29%) info
Market Cap: $2.798B info
CHRN
Oct 01, 2026, 5:40 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $20.29
Real-time Price: $19.15 info
Change: -$1.14 (-6%) info
Market Cap: $2.798B info
CHRN
Sep 22, 2026, 5:15 PM EDT
Filing Type: PRER14A
Importance Score:
7
Price at Filing: $21.62
Real-time Price: $19.15 info
Change: -$2.47 (-11%) info
Market Cap: $2.798B info
CHRN
Aug 27, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.74
Real-time Price: $19.15 info
Change: -$1.58 (-8%) info
Market Cap: $2.798B info
CHRN
Aug 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $22.90
Real-time Price: $19.15 info
Change: -$3.75 (-16%) info
Market Cap: $2.798B info
CHRN
Aug 19, 2026, 5:16 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $24.21
Real-time Price: $19.15 info
Change: -$5.06 (-21%) info
Market Cap: $2.798B info
CHRN
Jun 30, 2026, 5:14 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $22.66
Real-time Price: $19.15 info
Change: -$3.51 (-15%) info
Market Cap: $2.798B info
CHRN
Jun 26, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.09
Real-time Price: $19.15 info
Change: -$2.94 (-13%) info
Market Cap: $2.798B info
CHRN
Jun 04, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.31
Real-time Price: $19.15 info
Change: -$4.16 (-18%) info
Market Cap: $2.798B info
CHRN
May 20, 2026, 5:14 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $15.35
Real-time Price: $19.15 info
Change: +$3.80 (+25%) info
Market Cap: $2.798B info
CHRN
May 12, 2026, 8:30 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
10
Price at Filing: $14.38
Real-time Price: $19.15 info
Change: +$4.77 (+33%) info
Market Cap: $2.798B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets